Languages
  • Deutsch
  • Español
  • français
  • русский
  • العربية
  • info@iozk.de
    • Deutsch Deutsch German de
    • English English English en
    • Español Español Spanish es
    • Русский Русский Russian ru
    IOZK
    • Home
    • The IOZK
      • Philosophy
      • Team
      • Treatment Center
      • Laboratories
      • Directions and Accommodation
      • Patients Pamphlet
    • The IOZK Immunotherapy
      • IOZK Immunotherapy
      • The Vaccine IO-VAC®
      • The Treatment
      • IOZK Immunotherapy for Different Types of Cancer
      • Therapy Costs
      • FAQ
    • Expert Knowledge
      • IOZK Publications
      • Publications
      • Interesting Facts
    • News
    • Contact
    • Search
    • Menu

    Stefaan Van Gool MD. PhD.

    Medical Director Translational Oncology

    Tumour immunologist with specialisation in brain tumours

    Stefaan Van Gool MD. PhD., is a specialist in paediatric haemato-oncology with a focus on brain tumours. From 2001 to 2004, he was Chief Clinical Investigator at the Scientific Research Fund Flanders. Between 2006 and 2016, he held a full professorship at the Faculty of Medicine of the Catholic University of Leuven. From 2012 to 2015, he was head of the Paediatric Immunology Laboratory. He is the author of nearly 200 scientific articles in international journals.

    In recognition of his scientific achievements, he was awarded a number of honours:

    1995 Schweisguth Prize of the International Society of Paediatric Oncology
    1996 Nycomed Prize of the International Society of Paediatric Oncology
    1998 Rik en Nel Wouters Foundation Prize for Cancer Research (with Ludwig Van den Hove)
    From 2005 to 2009 he was the coordinator of the European Expert Group on High Grade Glioma
    Since 2008, he has been a member of the Supreme Health Court in Belgium
    From 2014 to 2017, he served as co-chair of the Brain Tumour Working Group of the European Society for Paediatric Oncology.

    At the IOZK, he is the head of the medical team and is responsible for the planning and implementation of the IOZK immunotherapy. In drug manufacturing, he acts as a Qualified Person (GMP) and Responsible Medical Person.

    “Since every tumour is different, the best results are achieved by targeting the unique tumour cell type with the patient’s own dendritic cells”

    Stefaan Van Gool MD. PhD.

    Compilation: Scientific contributions and international publications by Stefaan Van Gool MD. PhD

    Stefaan van Gool appointed as editor of a special issue by the Journal of Molecular Sciences

    2023-01-23/in Brain Tumors in Children, IOZK publications /by IOZK
    Read more
    https://www.iozk.de/wp-content/uploads/2020/11/IOZK_team_van-gool_175828-ret.jpg 518 690 IOZK https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg IOZK2023-01-23 16:16:322023-01-25 09:17:23Stefaan van Gool appointed as editor of a special issue by the Journal of Molecular Sciences

    Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019

    2019-07-14/in IOZK announcements, IOZK at conferences /by IOZK
    Read more
    https://www.iozk.de/wp-content/uploads/2019/03/Einladung-Symposium.jpg 999 2000 IOZK https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg IOZK2019-07-14 12:11:042019-07-22 16:07:17Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019

    IOZK presentation on the effects of multi-modal immunotherapy in a pontine glioma with the aid of liquid biopsy analysis

    2018-04-11/in IOZK at conferences, Other announcements /by root
    Read more
    https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg 0 0 root https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg root2018-04-11 18:59:532019-07-23 08:38:06IOZK presentation on the effects of multi-modal immunotherapy in a pontine glioma with the aid of liquid biopsy analysis

    IOZK presentation by Stefaan Van Gool: Immunotherapy for diffuse intrinsic pontine glioma (DIPG), at the annual meeting of the Society for Neuro-Oncology (SNO) in San Francisco

    2017-11-16/in IOZK announcements, IOZK at conferences /by IOZK
    Read more
    https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg 0 0 IOZK https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg IOZK2017-11-16 16:30:162019-07-23 08:50:43IOZK presentation by Stefaan Van Gool: Immunotherapy for diffuse intrinsic pontine glioma (DIPG), at the annual meeting of the Society for Neuro-Oncology (SNO) in San Francisco

    IOZK publication in Austin Oncology Case Reports on anti-tumor vaccines

    2017-03-01/in IOZK in the press, IOZK publications /by IOZK
    Read more
    https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg 0 0 IOZK https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg IOZK2017-03-01 12:12:242019-07-23 08:53:48IOZK publication in Austin Oncology Case Reports on anti-tumor vaccines

    Article on pediatric neuro-oncologist Stefaan Van Gool in the Washington Post

    2017-02-01/in IOZK in the press /by IOZK
    Read more
    https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg 0 0 IOZK https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg IOZK2017-02-01 12:17:052019-07-23 08:55:15Article on pediatric neuro-oncologist Stefaan Van Gool in the Washington Post

    Further Information on This Topic:

    • Team
    • IOZK Immunotherapy
    • Viruses against cancer
    • Dendritic Cells Inform the Immune System

    This post is also available in: German Spanish Russian

    The IOZK

    • Philosophy
    • Team
    • Treatment Center
    • Laboratories
    • Directions and Accommodation

    SPECIALISTS IN IMMUNO-ONCOLOGY

    NEW POSTS

    • Stefaan van Gool appointed as editor of a special issue by the Journal of Molecular Sciences
    • Award for groundbreaking discovery in immunotherapy goes to Prof. Shimon Sakaguchi
    • Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
    • Professor Volker Schirrmacher from the IOZK opened the Symposium on Tumor Immunology at Kiel University with a talk about research on oncolytic viruses in conjunction with a personalized immunotherapy for cancer.
    • International Journal of Oncology: “From chemotherapy to biological therapy”, Prof. Dr. Volker Schirrmacher

    Keywords

    Brain Tumor Checkpoint Inhibitors Chemotherapy Dendritic Cells Dr. Wilfried Stücker Hyperthermia Immunotherapy IO-Vac IOZK-Symposium IOZK Immunotherapy IOZK Team of Experts Liquid Biopsy Newcastle Disease Virus Nobel Prize in Medicine Oncology Oncolytic Viruses Paul Ehrlich Award Personalized Medicine Pontine Glioma Prof. Dr. rer. nat. Volker Schirrmacher Prostate Cancer Publications by Stefaan Van Gool MD. PhD. Stefaan Van Gool MD. PhD. Target Therapy Virotherapy
    IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
    Hohenstaufenring 30–32
    50674 Cologne | Germany

    T: +49 (0)221 – 420 399 25
    F: +49(0)221 - 420 399 26
    E-Mail: info@iozk.de

    The IOZK

    • Philosophy
    • Team
    • Treatment Center
    • Laboratories
    • Directions and Accommodation

    The IOZK Immunotherapy

    • IOZK Immunotherapy
    • The Vaccine IO-VAC®
    • The Treatment
    • IOZK Immunotherapy for Different Types of Cancer
    • Therapy Costs
    • FAQ

    News

    • Stefaan van Gool appointed as editor of a special issue by the Journal of Molecular Sciences
    • Award for groundbreaking discovery in immunotherapy goes to Prof. Shimon Sakaguchi
    • Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
    © 2019 IOZK Immun-Onkologisches Zentrum Köln
    • Privacy Statement
    • Cookie Settings
    Scroll to top